Medtronic starts brain stent trial:
This article was originally published in Clinica
The first US patient has been treated with Medtronic's INX neurovascular stent in a feasibility study on atherosclerotic disease. The study, at the State University of New York in Buffalo, follows an earlier feasibility study on intracranial wide-necked aneurysms. The INX stent has been specially designed for use in the highly tortuous vessels at the skull base and will be tested in a broad range of sizes.